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Introduction 
Vanadium(IV) oxido complexes with Schiff bases are one of 
the most important issues in modern coordination chemistry 
[1-5]. The interesting properties of these type of compounds 
are related to the flexibility of the vanadium not only connect-
ed with possible geometries (both penta- and hexa-coordinated 
complexes can be isolated) but also with variety of oxidation 
states of the metal centre (from +3 to +5). In project, presented 
in this issue, we studied mainly the insulin mimetic properties 
of such complexes, but also correlation between physicochem-
ical properties (such as structure, oxidation state of vanadium, 
complex stability, redox potentials etc.) and biological activity. 
It is worth to note, that the insulin-mimetic properties of vana-
dium complexes are known from decades [6-10], and several as 
BMOV or BEOV are used now as standards in diabetes studies 
investigations [11-15]. What is more, the anticancer, antifungal 
and antibacterial activities of vanadium complexes are also well 
recognized [16-18]. In case of vanadium different ligands were 
investigated in the study of insulin mimetic properties, maltol 
and its derivatives were found to be especially active [19,20]. 
The main problem is that the bidentate ligands were found to be 
released in organisms digestion system, resulting also in redox 
reactions leading to V(V) or V(IV) moieties and the role of va-
nadium complexes could be reduced to activity of simple VO2+ 
ions [21]. In last year’s Schiff bases were also intensively studied 
as ligands, as they can be used as models of biological systems 
[22-24]. This is related not only to the C=N bond presence but 
also to the possibility of utilization many biologically active al-
dehydes and amines in their synthesis. 
 In this paper we described the synthesis and physicochem-
ical characterization of vanadium(IV) complex with tridentate 
ONO hydrazone Schiff base ligand derived from 2,3-dihydroxy-
benzaldehyde and phenylacetic hydrazide. The use of tridentate 
ligand makes the complexes much more stable, and in biologi-
cal activity studies, presented later in this issue, we observe a 
huge change of biological activity using different ONO ligands 
indicating that complexes in unchanged (or at least with ONO 
ligand still coordinated to vanadium) form passes to the cells. 
The X-ray structure measurement as well as the elemental anal-
ysis, magnetic susceptibility, IR, UV-Vis spectra and cyclic 
voltammetry are presented and indicate the coordination of the 
oxido, Schiff base and 1,10-phenanthroline ligands to the vana-
dium(IV) center. The 1,10-phenanthroline was used as a co-li-
gand to increase the complex stability and to fill the coordina-
tion sphere of V(IV). 
Materials and Methods 
[VO(acac)2], 1,10-phenanthroline (phen), phenylacetic hy-
drazide and 2,3-dihydroxybenzaldehyde were of analytical 
grade (Aldrich) and were used as supplied. Ethanol (98%) of 
pharmaceutical grade was from Polmos, all other solvents were 
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of analytical grade and were used as supplied. BaSO4 was of 
spectroscopic grade (Japan). Bu4NPF6 was synthesized from 
Bu4NBr and KPF6 by a standard method [25] and recrystallized 
from acetone. Microanalysis of carbon, hydrogen and nitrogen 
were performed using Elementar Vario MICRO Cube elemental 
analyzer. The electronic absorption spectra were recorded with 
Shimadzu UV-3600 UV-Vis-NIR spectrophotometer equipped 
with a CPS-240 temperature controller. Diffuse reflectance 
spectrum was measured in BaSO4 pellets with BaSO4 as a ref-
erence on Shimadzu UV-3600 UV-VIS-NIR equipped with an 
ISR-240 integrating sphere attachment in 200-3600 nm range. 
IR spectrum was recorded on a Bruker EQUINOX 55 FT-IR 
spectrophotometer in KBr pellets. The magnetic susceptibility 
measurement was performed on a SHERWOOD SCIENTIFIC 
magnetic susceptibility balance. Cyclic voltammetry measure-
ments were carried out in DMSO with [Bu4N]PF6 (0.1 M) as the 
supporting electrolyte, using Pt working and counter and Ag/
AgCl as reference electrodes on an AUTOLAB/PGSTAT 128 
N Potentiostat/Galvanostat. E1/2 values were calculated from the 
average anodic and cathodic peak potentials, E1/2 = 0.5(Ea + Ec). 
The redox potentials were calibrated versus ferrocene (0.440 V 
versus SHE), which was used as an internal potential standard 
for measurements in organic solvents to avoid the influence of a 
liquid junction potential; the final values are reported versus the 
standard hydrogen electrode (SHE). 
Synthesis 
The reaction was carried out in one step. The Schiff base ligand 
L (N’-[(E)-(2,3-dihydroxyphenyl)metylidene]-2-phenylacetohy-
drazide) was synthesized in situ from 2,3-dihydroxybenzalde-
hyde and phenylacetic hydrazide in 1 : 1 molar ratio and after 
completing the reaction vanadyl acetylacetonate was added. 
The reaction proceeds under anaerobic conditions (Ar) due to 
the fast oxidation of V(IV) to V(V) in condition used. The ad-
dition of phen as a co-ligand results in fast precipitation of the 
complex by filling the coordination sphere of vanadium and in 
stabilization of V(IV) oxidation state. 
[VO(L)(phen)], 1
2,3-dihydroxybenzaldehyde (0.207 g, 1.5 mmol) and pheny-
lacetic hydrazide (0.225 g, 1.5 mmol) in 50 ml of EtOH were 
refluxed for 14 minutes under Ar yielding a transparent light 
yellow solution. Then [VO(acac)2] (0.398 g, 1.5 mmol) was add-
ed and the mixture was refluxed for 45 minutes giving dark-
brown transparent solution. Then phen (0.271 g, 1.5 mmol) was 
added and reflux was continued for 6 minutes. The mixture was 
left aside for cooling and after 2 hours the black precipitate was 
filtered off, washed with EtOH and dried in air. Yield 0.464 g. 
MW = 515.41. Calculated for C27H20N4O4V: C, 62.92; H, 3.91; N, 
10.87 %. Found: C, 61.88; H, 3.94; N, 10.52 %. Magnetic suscep-
tibility measurement, µ = 1.41 µB.
Crystallographic data collection and structure  
refinement
Diffraction intensity data for single crystal of the compound 
(1) were collected at room temperature on a KappaCCD (No-
nius) diffractometer with graphite-monochromated Mo Kα 
radiation (λ = 0.71073 Å). Cell refinement and data reduction 
were performed using firmware [26, 27]. Positions of all of 
non-hydrogen atoms were determined by direct methods us-
ing SHELXL-2017/1 [28]. All non-hydrogen atoms were refined 
anisotropically using weighted full-matrix least-squares on F2. 
Refinement and further calculations were carried out using 
SHELXL 2017/1 [28]. All hydrogen atoms joined to carbon at-
oms were positioned with an idealized geometries and refined 
using a riding model with Uiso(H) fixed at 1.5 Ueq of C for methyl 
groups and 1.2 Ueq of C for other groups. The hydrogen atom of 
-OH (O8) substituent was found in the difference-Fourier map 
and refined with an isotropic thermal parameter. The figures 
were made using DIAMOND software [29]. CCDC 1851403 
contains the supplementary crystallographic data for the com-
plex. These data can be obtained free of charge from the Cam-
bridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/
data_request/cif.
Results and Discussion 
The reaction of [VO(acac)2] with Schiff base ligand L 
(N’-[(E)-(2,3-dihydroxyphenyl)metylidene]-2-phenylacetohy-
drazide), synthesized in situ from 2,3-dihydroxybenzaldehyde 
and phenylacetic hydrazide in 1 : 1 in EtOH solvent under an-
aerobic conditions, results in formation of dark brown solution. 
Addition of phen results in solution colour change to dark red 
and fast precipitation of complex 1 and stabilization of +4 oxida-
tion state of vanadium. Absence of phen results in sensitivity of 
complex solution on oxygen and formation of the mixture of the 
products. The magnetic susceptibility measurement indicates on 
V(IV) oxidation state in 1. Complex is stable in air, soluble in 
organic solvents and almost insoluble in water. 
1. Crystal structure 
The complex crystallizes in the monoclinic space group P21/c 
with the asymmetric cell unit containing one molecule of 
[VOL(phen)] complex. The crystallographic data and detailed 
information on the structure solution and refinement for 1 are 
given in Table 1 while the molecular structure with the atom 
labelling scheme is illustrated in Fig. 1. The selected bond pa-
rameters are summarized in Table 2.
As depicted in Fig. 1 the oxidovanadium cation (VO2+) is me-
ridionally coordinated by the L2- tridentate hydrazone ligand, 
through the phenolate oxygen (O7), azomethine nitrogen (N10) 
and enolate oxygen (O13) and facially by bidentate phen ligand 
(N23, N34). The V1 atom presents a slightly distorted O3N3 octa-
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hedral environment with the O7, N10, O13 atoms from the LONO2- 
ligand and N23 from the Lphen molecule defining the equatorial 
plane. The second nitrogen atom of phen (N34) and the Ooxido 
(O21) occupy the axial positions (difference between the V1-N34 
and V1-O21 is 0.743 Å). The L ligand of the complex appears to 
be strongly twisted which is noticeable on the basis of the value 
of the dihedral angle between dihydroxyphenyl and phenyl rings 
(70.95˚). The presented structure of 1 is the first vanadium com-
plex listed in the literature, with phenylacetic hydrazide or with 
Schiff bases with this component, thus it is difficult to compare 
the bond lengths and angles with similar complexes. In litera-
ture the complexes with copper, silver, nickel and manganese are 
known, in most cases they are not monomers [30–34]. For ligand 
L dihedral angle between dihydroxyphenyl and phenyl rings is 
81.71o. For monomeric complexes it can be smaller; 70.81o for 
square planar copper [30], 78.23o for octahedral copper [30] and 
bigger as for silver complex 85.38o [33]. For polymeric complexes 
the lowest angle was found for hexameric manganese complex 
– 68.80o [34], for trimeric Ni(II) complex -80.84o [31] and for di-







Unit cell dimensions a = 10.2890(3) Å α = 90°
b = 16.0410(5) Å β = 97.106(2)°
c = 14.3930(4) Å γ = 90°
Volume 2357.26(12) Å3
Z 1
Density (calculated) 1.464 Mg/m3
Absorption coefficient 0.465 mm-1
F(000) 1068
Crystal size 0.150 x 0.140 x 0.050 mm3
Theta range for data collection 2.913 to 27.504°.
Index ranges -13≤h<=13, -20≤k≤20, -18≤l≤18
Reflections collected 19452
Independent reflections 5393 [R(int) = 0.0475]
Completeness to theta = 25.242° 99.7 % 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5393 / 0 / 338
Goodness-of-fit on F2 1.070
Final R indices [I>2sigma(I)] R1 = 0.0486, wR2 = 0.1059
R indices (all data) R1 = 0.0759, wR2 = 0.1175
Largest diff. peak and hole 0.449 and -0.346 e.Å-3
Table 1. Crystal data and structure refinement for 1
Figure 1. The asymmetric part of the unit cell of the complex 1 with adopted 
atomic numbering scheme. All non-hydrogen atoms are represented at 30% 
probability thermal ellipsoids
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The packing scheme, shown in Fig. 2, indicates the zig-zag 
type of complex arrangement with the aromatic rings forming 
an s shape chains. Packing reveals that the complex molecules 
are stabilized by three types of hydrogen bonds and additionally 
by two types of C-Hπ and two ππ interactions which are 
summarized in Tables 3, 4 and 5. Fig. 3 and 4 show the π inter-
actions in 1. The hydrogen bond distances are relatively short, 
but the <(DHA) angle is much lower than 180o indicating that 
they are very weak. The interesting is the bifurcated hydrogen 
bond between O7, O8 and N11. All these interactions are respon-
sible for self-assembly of the complex molecules in layers (Fig. 
2) and stabilization of the 3D structure. In the vanadium com-
plex, studied earlier, the mixture of isomers with the different 
position of 5- and 6-membered ring of ONO ligand versus phen 
ligand was observed [35]. In 1 rather unusual case of only one 
isomer presence in cell unit is observed.
Table 2. Selected bond lengths [Å] and bond angles [o] in 1























































































































D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
C(24)-H(24)...O(21) 0.93 2.48 2.944(4) 110.8
O(8)-H(8)...O(7) 0.77(3) 2.25(3) 2.663(2) 114(3)
O(8)-H(8)...N(11)1 0.77(3) 2.26(4) 2.914(3) 143(3)
Symmetry transformations used to generate equivalent atoms: 1 x,-y+1/2,z+1/2
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Cg(1): N(23)-C(22)-C(27)-C(26)-C(25)-C(24),  
Cg(2): C(22)-C(27)-C(28)-C(29)-C(30)-C(35)
Table 5. C-H…π interactions in 1
H…Cg X-H..Cg X…Cg
C(17)-H(17)…Cg(3)[2-X,-1/2+Y,1/2-Z]  2.81 145 3.607(4)




The IR spectrum of 1 in KBr (in 400-4000 cm-1) is presented in 
Fig. 5. The most important is the very strong band at 962 cm-1, 
typical for V(IV) complexes [36, 37]. The band at 1610 cm-1 can 
be attributed to imino C=N bond typical for Schiff bases and 
characteristic bands for phen at 725, 1424 and 1515 cm-1 [38]. 
In other region the bands of Schiff base ligand components are 
observed. The absence of bands of solvent molecules confirms 
the complex composition.
The UV-Vis solution spectra were measured in 200 – 900 nm 
range and are presented in Fig. 6. The bands in UV part are a 
superposition of the phen and L ligands while that above 400 
nm to metal-to-ligand charge-transfer (MLCT) connected with 
Schiff base ligand (L). The MLCT character of the band at ca. 
410 nm is confirmed by its solvatochromism, shown in Fig. 6. In 
Figure 2. The crystal packing in 1 through [001] direction
Figure 4. The 3D supramolecular network of 1 formed through hydrogen 
bonds. H-atoms (without H17 and H26) are omitted for clarity
Figure 5. The IR spectrum of 1 in KBr.
Figure 3. The 3D supramolecular network of 1 formed through hydrogen 
bonds. H-atoms (without H24 and H8) are omitted for clarity
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DMF and DMSO due to the solvent cut-off range, bands below 
315 nm cannot be observed. 
The molar absorption coefficients in DMSO are 2.91·103 
dm3M-1cm-1 (for 394 nm band) and 9.6·103 dm3M-1cm-1 (for 
329 nm band). The intensity of these bands indicates on their 
charge-transfer (CT) character. Due to low solubility of the com-
plex in the studied solvent, d-d transitions are not observed in 
solution. The more interesting is the reflection spectrum, pre-
sented in Fig. 7 after Kubelka-Munk transformation, where 
band at 851 cm-1 and shoulder at ca. 722 nm are observed. These 
bands can be attributed to d-d transitions of V(IV), the presence 
of two bands can be induced by the distortion of octahedron, 
typical attributed to the Jahn-Teller effect of d1 configuration of 
V(IV). In the UV part the bands attributed to phen and Schiff 
base ligands (at 228, 275 and 348 nm) are observed. The bands 
at 424 and 521 nm can be attributed to CT transitions of L and 
phen ligand respectively. The solutions of 1 in organic solvents 
were found to be relatively stable in time, and after several hours 
only small changes in spectra can be detected.
3. Cyclic voltammetry measurements
The cyclic voltammetry measurements results of 1 in DMSO 
are presented in Fig. 8. Pt working and counting, Ag/AgCl as 
a reference electrode, 0.1M Bu4NPF6 as electrolyte were used. 
The irreversible oxidation peak at 0.589 V can be attributed to 
V(IV/V) redox couple. The peak position is almost independent 
on scan speed, as shown in inset of the Fig. 8. Such a behavior is 
rather typical for reversible redox couple, the lack of reduction 
peak can be interpreted as chemical reduction following the ox-
idation process. The presence of two reduction peaks at -0.208V 
and -6.00 V is in agreement with this observation and these 
peaks can be attributed to reduction of side products of V(V) 
chemical reduction and they are not observed when scan range is 
reduced (see middle inset in Fig. 8). The reversible process at E1/2 
= -1.39 V with ΔE = 108 mV at 100 mV·s-1 is attributed to phen 
ligand reduction (phen + e- = phen-). 
Conclusions
The new complex of V(IV) with ONO tridentate, oxido and phen 
ligands was isolated and described. It was found to be promising 
for future investigation of its biological activity, due to its sta-
bility in solid state and in solvent studied. The addition of phen 
results in stabilization of +4 oxidation state of vanadium. The 
X-ray crystal structure shows, that only one isomer is present 
in the unit cell. The question which still requires further inves-
tigations is if this is the only product of the synthetic procedure 
or 1 is a mixture of isomers, but only one of them was chosen 
for measurements. We could not distinguish this basing on oth-
er measurements till now. The cyclic voltammetry shows, that 
V(IV) can be relatively easy oxidized to V(V), but this induces 
chemical reactions. Such a behavior may be very important for 
biological activity of 1 as insulin mimetic compound. 
Figure 6. The electronic spectra of 1 in different solvents, d = 1 cm
Figure 8. The cyclic voltammetry measurements of 1 in DMSO. Pt working 
and counting, Ag/AgCl as a reference electrode, 0.1M Bu4NPF6 as electrolyte. 
Scan speed 100 mV·s-1. Insets, scan speed 100 mV·s-1, for measurements at 
different scan speeds it vary from 20 to 250 mV·s-1
Figure 7. The reflection spectrum of 1 after Kubelka-Munk transformation
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